Abstract
This paper describes the development and validation of an isocratic LC-UV method for the assay of sitagliptin phosphate in tablets, a drug recently approved for the treatment of type 2 diabetes mellitus (DM). The method employs a Phenomenex® C18 column (150mm x 4.6mm I.D., 5μm) with 0.025 M phosphate buffer pH 6.8: acetonitrile (60:40, v/v) as mobile phase, at a 0.8 mL min-1 flow rate and UV detection at 267 nm. The chromatographic separation was obtained within a retention time of 3.7 min. The method was linear (r = 0.9999) in the range of 25-75 μg.mL-1. The method’s specificity and stability-indicating capability were proved through force degradation studies, being the peak purity evaluated by PDA detector. Sitagliptin phosphate was exposed to oxidative, hydrolytic and photolytic stress conditions, and no interference from degradation products was observed. The method has shown good and consistent recoveries (mean value 100.0%) with low intra and inter-day relative standard deviation (RSD). In robustness study, it was observed that peak area was unaffected by small changes in critical factors. The validated method can be successfully applied to determine sitagliptin in tablets and in stability studies.
Keywords: Liquid chromatography, method validation, sitagliptin phosphate, sitagliptin assay, stability-indicating, sitagliptin tablets, type 2 diabetes mellitus
Current Analytical Chemistry
Title:A Simple Stability-Indicating LC-UV Method to Assay Sitagliptin Phosphate in Tablets
Volume: 8 Issue: 4
Author(s): Aline Ravanello, Leila Schreiner Delgado, Ana Isa Pedroso Marcolino, Cristiane Franco Codevilla, Andrea Ines Horn Adams and Clarice Madalena Bueno Rolim
Affiliation:
Keywords: Liquid chromatography, method validation, sitagliptin phosphate, sitagliptin assay, stability-indicating, sitagliptin tablets, type 2 diabetes mellitus
Abstract: This paper describes the development and validation of an isocratic LC-UV method for the assay of sitagliptin phosphate in tablets, a drug recently approved for the treatment of type 2 diabetes mellitus (DM). The method employs a Phenomenex® C18 column (150mm x 4.6mm I.D., 5μm) with 0.025 M phosphate buffer pH 6.8: acetonitrile (60:40, v/v) as mobile phase, at a 0.8 mL min-1 flow rate and UV detection at 267 nm. The chromatographic separation was obtained within a retention time of 3.7 min. The method was linear (r = 0.9999) in the range of 25-75 μg.mL-1. The method’s specificity and stability-indicating capability were proved through force degradation studies, being the peak purity evaluated by PDA detector. Sitagliptin phosphate was exposed to oxidative, hydrolytic and photolytic stress conditions, and no interference from degradation products was observed. The method has shown good and consistent recoveries (mean value 100.0%) with low intra and inter-day relative standard deviation (RSD). In robustness study, it was observed that peak area was unaffected by small changes in critical factors. The validated method can be successfully applied to determine sitagliptin in tablets and in stability studies.
Export Options
About this article
Cite this article as:
Ravanello Aline, Schreiner Delgado Leila, Isa Pedroso Marcolino Ana, Franco Codevilla Cristiane, Ines Horn Adams Andrea and Madalena Bueno Rolim Clarice, A Simple Stability-Indicating LC-UV Method to Assay Sitagliptin Phosphate in Tablets, Current Analytical Chemistry 2012; 8 (4) . https://dx.doi.org/10.2174/157341112803216771
DOI https://dx.doi.org/10.2174/157341112803216771 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
Call for Papers in Thematic Issues
Advancements in biomedicine, corrosion inhibition/monitoring, and lubrication of carbon dots
Carbon dots, a class of carbon-based nanomaterials, have garnered substantial interest in various scientific and engineering fields due to their unique properties, including excellent optical properties, outstanding biocompatibility, easy preparation, good dispersity, ultrasmall size, low toxicity and environmental friendliness. This special issue of Current Analytical Chemistry aims to showcase cutting-edge ...read more
Analytical methods for environmental and food analysis
In recent years, the study of the chemical composition of food and the environment depends on analytical methods in order to acquire information about the chemical composition, processing, quality control and contamination of soil, water, air, plants and foods, aspects very important for food safety and environmental quality control. There ...read more
Applications of artificial intelligence in chemical analysis
Artificial intelligence (AI) has demonstrated its versatility in almost all scientific fields, especially analytical chemistry, which is leading the way in the integration of AI. According to Chemical Abstract Services, one of the major disciplines contributing to AI-related publications and patents is analytical chemistry. That?s because techniques such as deep ...read more
Bioanalytical and Biosensor Technologies for Target Molecules
Bioanalytical and biosensor technologies constitute the core of detecting and sensing diverse molecules within living organisms, encompassing proteins, DNA, small molecular metabolites, and beyond. These molecules assume pivotal roles in biological processes, rendering their analysis and sensing indispensable for comprehending biological phenomena and unraveling disease mechanisms. In the current landscape ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery PPARγ and Early Human Placental Development
Current Medicinal Chemistry Cardiovascular Complications in Patients with Turner’s Syndrome
Current Pharmaceutical Design Immunomodulatory Role of Arsenic in Regulatory T Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Prognostic Value of White Blood Cell Counts and C-reactive Protein in Acute Ischemic Stroke Patients After Intravenous Thrombolysis
Current Neurovascular Research Subject Index To Volume 12
Current Pharmaceutical Design Drug Development and the Importance of Ethnicity: Lessons from Heart Failure Management and Implications for Hypertension
Current Pharmaceutical Design Modifiable Risk Factors Associated with Alzheimer’s Disease with Special Reference to Sleep Disturbance
CNS & Neurological Disorders - Drug Targets Pancreas Development and β-Cell Differentiation of Embryonic Stem Cells
Current Medicinal Chemistry Hydrofiber Dressing and Wound Repair: Review of the Literature and New Patents
Recent Patents on Inflammation & Allergy Drug Discovery Metabolic Syndrome and Its Effect on the Brain: Possible Mechanism
CNS & Neurological Disorders - Drug Targets Erectile Dysfunction and Diabetes Mellitus: Mechanistic Considerations from Studies in Experimental Models
Current Diabetes Reviews Impact of Diabetes on Cardiac and Vascular Disease: Role of Calcium Signaling
Current Medicinal Chemistry Lipoprotein (a) Management: Lifestyle and Hormones
Current Medicinal Chemistry Cell-Penetrating Peptides: Mechanisms and Applications
Current Pharmaceutical Design Disseminated TB in an Immunocompetent Patient: A Case Report
Infectious Disorders - Drug Targets Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Insulin and the Blood-Brain Barrier
Current Pharmaceutical Design The Etiology of Hypertension in the Metabolic Syndrome Part Three: The Regulation and Dysregulation of Blood Pressure
Current Vascular Pharmacology Formulation and Pharmacodynamic Evaluation of Glibenclamide Incorporated Niosomal Gel
Current Drug Discovery Technologies